Trial NCT01712945

View at ClinicalTrials.gov 
Org. Study IDs: 2011-005606-30

Last trial update was posted on 2019-04-30

MeSH Interventions

Alemtuzumab

MeSH Conditions

Multiple Sclerosis Sclerosis

Other Conditions


Stopping Reasons

interim anlaysis failed: palifermin does not promote thymopoeisis after alemtuzumab

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID